基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the complete record of transactions filed by Gsk Plc. Officer active across 2 companies, notably Theravance Biopharma, Inc.. Aggregated, 4 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €59.2m. History available since 16 September 2022. The latest transaction was filed on 11 December 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
GSK PLC is a declarant with 4 filings in total. Across the 4 sampled recent filings, buys amount to EUR 59177366 and sells to EUR 0, over the period from 2022-09-20 to 2025-12-15. The companies involved are Wave Life Sciences Ltd. and Theravance Biopharma, Inc., and the modal transaction nature reported is Acquisition.